Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 24 June 2026Incoming appointee
4 itemsScheduled Appointment DateThe Company's new director, scheduled retiring director and new executive officer will take office as of 25 September 2026. The new director, change in representative director and scheduled retiring director of コーア商事株式会社 will take effect as of 15 September 2026. The scheduled retiring director of コーアイセイ株式会社 and the new executive officer of コーアイセイ株式会社 will take effect as of 15 September 2026 and 1 July 2026, respectively. The appointment of directors is scheduled to be formally approved at the 12th Annual General Meeting of Shareholders to be held on 25 September 2026, while the appointment of executive officers is scheduled to be formally approved at a meeting of the Board of Directors following the conclusion of the Annual General Meeting of Shareholders on the same date.
Isoda Hideyuki (磯田秀幸)
Previous position－ (the Company)
New positionDirector (the Company)
Onuma Kenichi (大沼謙一)
Previous positionHead of Corporate Planning Office (the Company)
New positionExecutive Officer, Head of Corporate Planning Office (the Company)
Tachikawa Akira (立川彰)
Previous positionExecutive Officer, General Manager of Sales Department (コーア商事株式会社)
New positionDirector, General Manager of Sales Department (コーア商事株式会社)
Matsumoto Hiroatsu (松本広淳)
Previous positionHead of Zao Plant, Production Division (コーアイセイ株式会社)
New positionExecutive Officer, Head of Zao Plant, Production Division (コーアイセイ株式会社)
Departing officer
2 itemsDate of departureAs of 25 September 2026 (Koyama Toshinori (小山登志憲) of the Company); as of 15 September 2026 (Otsuka Ritsuko (大塚里津子) of コーア商事株式会社, and Koyama Toshinori (小山登志憲) of コーアイセイ株式会社 and コーアバイオテックベイ株式会社)
Koyama Toshinori (小山登志憲)Next role stated
Former PositionSenior Managing Director (the Company) and Director (コーアイセイ株式会社 and コーアバイオテックベイ株式会社)
New positionAdviser to the Company (the Company); not disclosed for the other positions
Otsuka Ritsuko (大塚里津子)Stepping down
Former PositionRepresentative Director and President (コーア商事株式会社)
New positionNot disclosed
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Koyama Toshinori (小山登志憲) is scheduled to become an adviser to the Company. Whether he will remain on the Board of Directors is not stated. No information is provided regarding Otsuka Ritsuko (大塚里津子).
Shareholders’ meeting approvalRequired. The proposal concerns the appointment of directors, and the meeting is scheduled for 25 September 2026. The appointment of executive officers is scheduled to be formally approved at a meeting of the Board of Directors following the conclusion of the Annual General Meeting of Shareholders on the same date.
| Item | Details |
|---|---|
| Resolution date | 24 June 2026 |
| Scheduled Appointment Date | The Company's new director, scheduled retiring director and new executive officer will take office as of 25 September 2026. The new director, change in representative director and scheduled retiring director of コーア商事株式会社 will take effect as of 15 September 2026. The scheduled retiring director of コーアイセイ株式会社 and the new executive officer of コーアイセイ株式会社 will take effect as of 15 September 2026 and 1 July 2026, respectively. The appointment of directors is scheduled to be formally approved at the 12th Annual General Meeting of Shareholders to be held on 25 September 2026, while the appointment of executive officers is scheduled to be formally approved at a meeting of the Board of Directors following the conclusion of the Annual General Meeting of Shareholders on the same date. |
| Date of departure | As of 25 September 2026 (Koyama Toshinori (小山登志憲) of the Company); as of 15 September 2026 (Otsuka Ritsuko (大塚里津子) of コーア商事株式会社, and Koyama Toshinori (小山登志憲) of コーアイセイ株式会社 and コーアバイオテックベイ株式会社) |
| Name of appointee | Isoda Hideyuki (磯田秀幸), Onuma Kenichi (大沼謙一), Tachikawa Akira (立川彰), Matsumoto Hiroatsu (松本広淳) |
| Appointee's new position | Director (the Company), Executive Officer, Head of Corporate Planning Office (the Company), Director, General Manager of Sales Department (コーア商事株式会社), Executive Officer, Head of Zao Plant, Production Division (コーアイセイ株式会社) |
| Appointee's previous position | － (the Company), Head of Corporate Planning Office (the Company), Executive Officer, General Manager of Sales Department (コーア商事株式会社), Head of Zao Plant, Production Division (コーアイセイ株式会社) |
| Name of departing officer | Koyama Toshinori (小山登志憲), Otsuka Ritsuko (大塚里津子) |
| Former position of departing officer | Senior Managing Director (the Company) and Director (コーアイセイ株式会社 and コーアバイオテックベイ株式会社), Representative Director and President (コーア商事株式会社) |
| New position of departing officer | Adviser to the Company (the Company); not disclosed for the other positions, Not disclosed |
| Whether the incumbent will remain in office | Koyama Toshinori (小山登志憲) is scheduled to become an adviser to the Company. Whether he will remain on the Board of Directors is not stated. No information is provided regarding Otsuka Ritsuko (大塚里津子). |
| Subject to Approval by the General Meeting of Shareholders | Required. The proposal concerns the appointment of directors, and the meeting is scheduled for 25 September 2026. The appointment of executive officers is scheduled to be formally approved at a meeting of the Board of Directors following the conclusion of the Annual General Meeting of Shareholders on the same date. |
Items this document does not state (10)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No specific reason for the changes is provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.